The etiology of chronic pancreatitis (CP) is complex and involves a subtle interplay between genetic and environmental factors. Most of the hitherto reported genes/loci affecting disease susceptibility encode proteins of the protease-antiprotease system of the pancreatic acinar cells. [1] [2] [3] [4] [5] [6] [7] A hybrid allele (CEL-HYB), involving the CEL gene (encoding pancreatic carboxyl ester lipase 8 ) and its tandemly linked pseudogene (CELP), was recently reported to be significantly overrepresented in CP cases as compared with controls, firstly in a discovery cohort of patients with familial CP and then in three replication cohorts of patients with idiopathic CP. 9 The CEL-HYB allele resulted from non-allelic homologous recombination (NAHR) occurring between CEL intron 10 and CELP intron 10′; replacement of the eleventh and last exon of CEL by CELP exon 11′ would yield a premature stop codon within the third "pseudo" 33-bp variable number tandem repeat (VNTR) 9 ( Figure 1A ). The mutant enzyme is more stable than its wild-type (WT) counterpart and induced autophagy in cellular models, 9 suggesting a novel pathogenic mechanism. However, since the patients analyzed in the original study 9 were solely of European ancestry, replication in independent populations of different ethnicity was warranted. 10 The detection of the CEL-HYB allele is dependent upon a long-range duplex PCR assay. 9 Using French CEL-HYB positive samples, we found that the originally described PCR assay 9 yielded better results under slightly modified conditions (see Supplementary
Material and Supplementary Figure 1) . Consequently, these modified conditions were employed to screen for the CEL-HYB allele in three Asian populations. We first analyzed a cohort of Han Chinese patients with idiopathic CP. The previously described CEL-HYBspecific 3.2-kb band was detected in 2.4% (19/799) of patients and 1.9% (20/1028) of controls (P = 0.64; Table 1 ). Sequencing of the 3.2-kb band-containing PCR products however revealed that none of these Chinese CEL-HYB alleles corresponded to that expected; instead, they invariably resulted from an NAHR event occurring within a 239-bp sequence tract affecting the intron 9/exon 10 boundary of CEL and the intron 9′/exon 10′ boundary of CELP (Supplementary Figure 2) . Hereafter, we term the previously reported disease-associated CEL-HYB allele 9 as CEL-HYB1 so as to distinguish it from this newly described allele, CEL-HYB2.
Closer inspection of the 39 Chinese CEL-HYB2 alleles revealed that they could be divided into two subtypes by reference to three single nucleotide polymorphisms (SNPs) present within the substituting CELP sequence (Supplementary Figure 2) ; 38 harbored the G allele of rs10901232A/G, the T allele of rs10901233C/T and the G allele of rs671412A/G (termed CEL-HYB2a), the sole exception harboring the alternative alleles of these three SNPs (termed CEL-HYB2b). We further genotyped two idiopathic CP cohorts from Japan and India. Results from the Japanese cohort were remarkably similar to those from the Chinese cohort whereas in the Indian cohort, only one control carried a CEL-HYB allele, and this corresponded to CEL-HYB2b ( Table 1 ). Note that a variant similar to CEL-HYB2 was mentioned in passing by Fjeld et al. 9 to be present in one European case and four controls, although no sequence details were presented. Sequencing of two corresponding French CEL-HYB positive samples revealed their identity to be CEL-HYB2b. In short, the PCR assay employed efficiently detects all three CEL hybrid alleles, the differentiation of which relies upon the sequencing of the respective PCR products.
Both CEL-HYB2a and CEL-HYB2b variants harbor premature stop codons within their chimeric exons 10 ( Figure 1A) ; their corresponding mRNAs could therefore be subject to significant degradation by nonsense-mediated mRNA decay (NMD). However, this might not be the case for CEL-HYB1 because mRNAs that harbor a stop codon in the final exon usually escape degradation by NMD. Figure 1C ). Then, we tested whether the mRNA expression level of CEL-HYB2a could be increased by treatment of the transfected cells with cycloheximide, a known NMD inhibitor 12 and found this to be the case ( Figure 1D ). Hence, we conclude that mRNA expression from the CEL-HYB2a allele is significantly reduced by NMD. This conclusion probably also applies to CEL-HYB2b owing to its high sequence similarity with CEL-HYB2a ( Figure 1A ).
In summary, contrary to our expectation, we failed to identify the CEL-HYB1 allele in any of the three Asian cohorts. Based on the allele frequency of CEL-HYB1 in healthy
German and French populations (0.4%), 9 the power to detect at least one CEL-HYB1 carrier among the cases is estimated to be >86%, even for the smallest cohort. Given that most rare variants (defined as a minor allele frequency of <0.5%) are population-specific, 13 CEL-HYB1 may be an ethnicity-specific disease risk factor, although this remains to be confirmed by replication in an independent cohort of European ancestry (e.g., the North American 
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Chinese, Japanese and Indian patients with idiopathic chronic pancreatitis (i.e. absence of a positive family history and any known precipitating factor such as alcohol abuse) and healthy controls from their corresponding general populations were recruited by the three leading Asian pancreatitis groups. A clinical diagnosis of chronic pancreatitis was based on two or more of the following criteria: (i) presence of a typical history of recurrent pancreatitis; (ii) radiological findings such as pancreatic calcification and/or pancreatic irregularities revealed by endoscopic retrograde pancreatography or by magnetic resonance imaging of the pancreas; and (iii) pathological sonographic findings. Informed consent was obtained from each patient and the study was approved by the respective ethics committees of the three leading Asian pancreatitis groups.
Screening for the CEL-HYB Allele
Screening for the disease-associated CEL-HYB allele (termed CEL-HYB1 in the present study) was performed in accordance with the previously reported method 9 but with some modified reaction conditions. Specifically, we performed the PCR reactions in total volumes of 10 μl containing 2 × GC buffer, 0.4 μM primer L11F (5'-GTCCCTCACTCATTCTTCTATGGCAAC-3'), 0.2 μM of the primers IAR (5'-TCCAAAGCCCTAGCAGTAACGA-3') and CELP VNTR-rev (5'-CTGTGGAGGGCATGGAACT-3'), 0.4 mM each dNTP, 0.5 U LA Taq DNA polymerase and 10-50 ng genomic DNA. These conditions work better than those originally described for genotyping the French CEL-HYB1 positive samples (Supplementary Figure 1) .
Sequencing the Positive Samples
Samples showing the CEL-HYB-specific 3.2-kb band 9 were subjected to Sanger sequencing using the previously published primers, S10F and S10R. 9 Crossover regions of the CEL-HYB alleles were assigned by evaluating the nucleotide positions that serve to discriminate the CEL and CELP sequences within the region of interest. To this end, we aligned CEL exon 10 and its partial flanking sequences against the corresponding CELP sequences, the discriminant nucleotides being clearly indicated (Supplementary Figure 2) .
The assessment of significance of the differences between the carrier frequencies of the CEL-HYB alleles in patients and controls was performed by means of two-tailed Fisher's exact test using StatCalc (2  ×  2  Tables)  from  Epi Info™ 7 (http://wwwn.cdc.gov/epiinfo/index.htm). The difference was regarded as being statistically significant when the P value was ≤ 0.05.
Construction of Expression Vectors for mRNA Expression Analysis in the Context of the Full-Length CEL-HYB1 and CEL-HYB2a Genomic Sequences
We PCR amplified the full-length (approximately 10-kb) genomic CEL-HYB1 and CELHYB2a sequences (going from the 5'-untranslated region of CEL to the 3'-untranslated region of the replacement CELP) from their corresponding carriers and cloned the resulting PCR products into the pcDNA3.1/V5-His-TOPO vector using previously described methods. 16, 17 Specifically, the long-range PCR was performed using 50 ng DNA in a 50 μL reaction mixture with 2.5 U TaKaRa LA Taq DNA polymerase, 8 μL dNTP Mixture (400 µM final), 5 µL 10 × PCR buffer system, and 1 μM each primer of primer pair A1 (Supplementary Table  1 ). Thermal cycling conditions were: initial denaturation at 94°C for 1 min, followed by 30 cycles of denaturation at 98°C for 10 s, annealing and extension at 68°C for 12 min, and a final extension step at 72°C for 10 min. PCR products of the expected size were purified using the NucleoSpin® Gel kit (Macherey Nagel) after gel electrophoresis. 3'-A overhangs were added to the purified products before being cloned into the pcDNA3.1/V5-His-TOPO vector (Invitrogen) in accordance with the manufacturer's instructions. Transformation was performed using XL10-Gold Ultracompetent Cells (Stratagene). Transformed cells were spread onto LB agar plates with 50 μg/ml ampicillin and incubated at 37°C overnight.
Plasmid constructs containing inserts in the right orientation were selected for simultaneously by two PCRs using the HotStarTaq Master Mix Kit (Qiagen). The first PCR amplifies a 235-bp fragment extending from the T7 promoter/priming site (located within the vector) to the exon 1/intron 1 boundary of CEL (i.e. primer pair A2 in Supplementary Table  1 ). The second PCR amplifies an approximately 1.3-kb fragment going from the beginning of CEL exon 10 to the BGH reverse priming site (located within the vector) (i.e. primer pair A3 in Supplementary Table 1) . Selected plasmids were then sequenced using primer S10F (see Supplementary Figure 2 ) to pick up those carrying the desired CEL-HYB1 or CEL-HYB2a variant.
Cell Culture, Transfection and Cycloheximide Treatment
Human embryonic kidney (HEK) 293T cells were cultured in DMEM nutrient mixture with 10% fetal calf serum. 3.5 x 10 5 cells were seeded per well of 6-well plates 24 hours prior to transfection. For conventional RT-PCR analyses (see below), 1 μg pcDNA3.1-CEL-HYB1 or pcDNA3.1-CEL-HYB2a plasmid, which were mixed with 3 μL Lipofectamine 2000 Reagent (Invitrogen), were used for transfection per well. For real-time quantitative RT-PCR analyses (see below), 500 ng pcDNA3.1-CEL-HYB1 or pcDNA3.1-CEL-HYB2a plasmid were mixed with 500 ng pGL3-GP2 minigene for transfection. Forty-eight hours after transfection, total RNA was extracted using the RNeasy Mini Kit (Qiagen). For the NMD inhibition experiment, 50 μg/mL (final concentration) cycloheximide (Sigma) were added to the cells 4 hours before RNA extraction.
Reverse Transcription
Reverse transcription (RT) was performed using the SuperScript II Reverse Transcriptase (Life Technologies) with 1 µg total RNA, 500 µM dNTPs, 5 µM 20mer-oligo(dT) and 10 mM DTT (Eurogentec). The resulting cDNAs were treated with 2U RNAseH (Life Technologies) to degrade the remaining RNA.
Conventional RT-PCR and Sequencing of the Resulting Products
Conventional RT-PCR was performed in a 25-μl reaction mixture containing 0.5 U KAPA HiFi HotStart DNA Polymerase (Kapa Biosystems), 1 μl cDNA and 0.3 µM each primer of primer pair A4 (Supplementary Table 1 ). Note that this primer pair was designed to amplify a full-length CEL-HYB1 or CEL-HYB2a transcript. The PCR program comprised an initial denaturation step at 95°C for 5 min, followed by 30 cycles of denaturation at 98°C for 20 s, annealing at 72°C for 15 s, and extension at 72°C for 3 min, and a final extension step at 72°C for 5 min.
RT-PCR products were cleaned using ExoSAP-IT® before being sequenced with five primers (Supplementary Table 2 ) by means of the BigDye Terminator v1.1 Cycle Sequencing Kit (Life Technologies).
Real-Time Quantitative RT-PCR
Real-time quantitative RT-PCR analyses were performed essentially as described elsewhere. 16 In brief, pcDNA3.1-CEL-HYB1 or pcDNA3.1-CEL-HYB2a was co-transfected with the previously constructed pGL3-GP2 minigene. 16 The target and reference genes were PCR amplified separately; target gene expression was determined using pGL3-GP2 minigene expression as a reference by means of the ∆∆Ct method in accordance with the Pfaffl efficiency-corrected calculation model. 18 Real-time quantitative RT-PCR was performed in a 25μL mixture containing 12.5 μL HotStarTaq Master Mix Kit (Qiagen), 1 μL 1:25 diluted cDNA, 0.5 µM SYTO9 (Life Technologies) and 0.3 μM each primer (primer pair A5 was employed for both CEL-HYB1 and CEL-HYB2a whilst primer pair A6 was used for the reference gene; Supplementary Table 1 ). The PCR program comprised an initial denaturation step at 95°C for 15 min, followed by 40 cycles of denaturation at 94°C for 45 s, annealing at 55°C for 30 s and extension at 72°C for 30 s. Quantitative analysis of each RT-PCR amplification was performed in triplicate on a Lightcycler 480II (Roche, Paris, France) using "relative quantification" and "2nd derivative maxima" options.
The difference between the expression levels of CEL-HYB1 and CEL-HYB2a (results from six independent transfection experiments) and that between expression levels of CELHYB2a with and without cycloheximide treatment (results from three independent transfection experiments) were assessed for significance by the Student's t-test. The difference was regarded as being statistically significant when the P value was ≤ 0.05. is singly underlined. The discriminant positions between the two paralogous sequences are indicated by numbered upwardly pointing arrows. The CEL-HYB2a variant harbors the G allele of rs10901232A/G, the T allele of rs10901233C/T and the G allele of rs671412A/G whereas the CEL-HYB2b variant harbors the alternative alleles of these three SNPs (the three affected sites are indicated by circles). The premature translation termination codon in the chimeric exon 10 of the CEL-HYB2b variant is indicated by a box. The two primers used for sequencing the breakpoint junctions of the CEL-HYB alleles, S10F and S10R, 9 
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